Semanteon Capital Management, LP Adma Biologics, Inc. Call Options Transaction History
Semanteon Capital Management, LP
- $157 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
228Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$243 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$170 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$141 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$140 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$104 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...